Unmatched accuracy in TMS
Nexstim (nexstim.com) scores 74 out of 100 on Brand Analyzer, placing it in the Brand-Ready tier among Healthcare brands, Technology brands, in the 41st percentile of 6897 Healthcare brands.
Nexstim is a Finnish medical device company founded in 2000 and headquartered in Helsinki. It develops navigated transcranial magnetic stimulation (nTMS) technology under the SmartFocus brand, using 3D imaging to precisely target brain regions for diagnostic and therapeutic purposes. The company's technology supports applications such as brain tumor surgery planning, depression treatment, and epilepsy diagnostics, serving neurosurgeons, radiotherapists, psychiatrists, and specialized clinics in neurology and psychiatry.
| Brand Name | Nexstim |
|---|---|
| Domain | nexstim.com |
| Industry | Healthcare, Technology |
| Founded | 2000 |
| Headquarters | Helsinki |
| Main Competitors | Magstim (73/100), Brainsway, Neuronetics (61/100), MagVenture, Localite |
Moz Domain Authority 36/100 vs category average 40 / leader 95 - limited third-party links, so AI systems rarely encounter mentions of the brand.
No Wikipedia presence was found - a major gap, since Wikipedia is among the most heavily weighted sources in AI training data.
The homepage meta description reads "To provide clinicians with precise, navigated brain stimulation technology that improves patient outcomes in neurology and psychiatry." (No meta description) - this is the summary AI engines are most likely to quote.
Structured data on the homepage: Twitter cards, canonical. Adding Organization and FAQ schema would further help AI crawlers parse the brand's identity.
AI-crawler access: robots.txt present, no AI bot restrictions - robots.txt controls whether engines like GPTBot and ClaudeBot can read the site at all.
Social footprint: verified profiles on YouTube, LinkedIn, X (Twitter), Facebook, Instagram, GitHub - consistent profiles reinforce the brand's identity across the web.
0 Reddit mentions - community discussion signals real-world reputation to AI models.
Live results from asking a general-purpose AI assistant about the brand, checked September 2026.
When asked "What is Nexstim?", Claude could identify the brand as of September 2026. Nexstim is a Finnish medical technology company that develops navigated brain stimulation systems, including NBS (Navigated Brain Stimulation) for pre-surgical mapping and NBT (Navigated Brain Therapy) using TMS for treating conditions like depression and chronic pain. Best known for Navigated transcranial magnetic stimulation (TMS) systems used for brain surgery planning and depression treatment.
When asked "Best brands similar to Nexstim?", Claude would recommend Nexstim as of September 2026. It's a recognized player in navigated TMS technology, a niche but important segment of neuromodulation and neurosurgical planning tools.
Common questions people ask in Google, ChatGPT, Claude, Gemini, Perplexity, and other AI search engines.
Nexstim's main competitors in Healthcare: Magstim (73/100), Neuronetics (61/100).
Sources: Brand Analyzer scan
Nexstim is a Finnish medical device company, founded in 2000 and based in Helsinki, that develops navigated transcranial magnetic stimulation (nTMS) technology for use in neurology and psychiatry.
Sources: Nexstim official site
Nexstim has low AI-search visibility, scoring 24/100 on Brand Analyzer's AI visibility composite (visibility 23, trust 15, recommendation 38). This estimates how likely AI engines like ChatGPT, Claude, Gemini and Perplexity are to know, trust, and recommend the brand.
Sources: Nexstim official site
Nexstim was founded in 2000. Nexstim operates in the Healthcare category. It is analyzed by Brand Analyzer across seven brand dimensions and AI-search visibility.
Sources: Wikidata
Nexstim is headquartered in Helsinki. Nexstim operates in the Healthcare category.
Sources: Wikidata
Nexstim offers SmartFocus nTMS, a navigated transcranial magnetic stimulation system that uses 3D imaging to precisely target and quantify brain stimulation. This technology is used for brain mapping in surgical planning and for therapeutic treatment of conditions such as depression, and has applications in epilepsy and pediatric care.
Sources: Nexstim official site
Nexstim designs and provides navigated brain stimulation systems, marketed as SmartFocus nTMS, that use 3D imaging to precisely target brain regions with an electric field (E-field) and quantify treatment dose. This supports both diagnostic brain mapping (e.g., for tumor surgery planning) and therapeutic applications such as depression treatment.
Sources: Nexstim official site
Nexstim scores 38/100 on Brand Analyzer's AI recommendation signal, indicating it is less likely to be surfaced when AI assistants like ChatGPT suggest Healthcare options. Recommendation depends on crawlability, structured data, and category authority.
Sources: Nexstim official site
Nexstim can improve AI discoverability by strengthening structured data (Organization and FAQ schema), maintaining an accurate Wikipedia/Wikidata entity, earning authoritative citations, and keeping content crawlable for AI bots. Brand Analyzer measures these as visibility, trust, and recommendation signals.
Sources: Nexstim official site
Nexstim's technology is used by healthcare professionals including neurosurgeons, radiotherapists, and psychiatrists, as well as clinics specializing in depression treatment, brain surgery planning, epilepsy, and pediatric care. Patients undergoing these treatments are also end users of the technology.
Sources: Nexstim official site
Nexstim is known for its navigated transcranial magnetic stimulation (nTMS) technology, particularly the SmartFocus system, which combines 3D imaging with precise E-field targeting for brain mapping and neuropsychiatric treatment.
Sources: Nexstim official site
Nexstim scores 24/100 for AI visibility - how well ChatGPT, Claude, Perplexity and Google AI Overviews can discover, identify and cite the brand.
Nexstim has a weak AI-visibility profile at 24/100 - a proxy for how readily ChatGPT, Perplexity and Google's AI Overviews can recognise and cite it. Its strongest area is recommendation likelihood (38/100) and its weakest is trust (15/100). It benefits from a Wikidata knowledge-graph entry and open access for AI crawlers (GPTBot, ClaudeBot, etc.). The main gaps holding it back: no clear Wikipedia entity to anchor it in LLM training data, a low Moz Domain Authority of 36/100 and thin schema.org structured data. In a live check, Claude could already identify Nexstim from memory (September 2026) - a sign these signals are paying off.
The score combines seven dimensions - name quality, digital presence, visual identity, messaging clarity, trust foundation, AI discoverability, and brand authority - into a single objective benchmark.
Ranked closest to Nexstim: New Hospitals (ნიუ ჰოსპიტალსი) (74/100), Neurophet (74/100), Novo Holdings (74/100), National Student Nurses' Association (74/100).
A step up - brands to learn from: Zurich Insurance Group (81/100), ZOLL Data Systems (81/100).
Category leader: Booksy (96/100).
Brand Analyzer is built by DataEase AI. Track your brand in ChatGPT, Gemini and Perplexity.